Josh Riggs is CEO & President at Insight Molecular Diagnostics Inc. (IMDX). They have made 1 open-market trade across 1 company since 2024, most recently 2026-03-26.
CIK 0001956391
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCX | BUY | 2024-04-11 | 2024-04-15 | $2.95 | $10K | -4.7% | +15.2% | +31.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.